Pages that link to "Item:Q7808"

← Subsection in publication (Q7808)

What links here

Page:  Namespace:  all (Main) Talk User User talk Wikibase.slis.ua.edu Wikibase.slis.ua.edu talk File File talk MediaWiki MediaWiki talk Template Template talk Help Help talk Category Category talk Item Item talk Property Property talk Module Module talk   Invert selection

Filters

Show transclusions | Hide links | Hide redirects

The following pages link to Subsection in publication (Q7808):

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

• Methods: Data Collection (Subsection from DOI: 10.7326/m20-0504) (Q7923) ‎ (← links)
• Methods: Statistical Analysis (Subsection from DOI: 10.7326/m20-0504) (Q7924) ‎ (← links)
• Methods: Role of the Funding Source (Subsection from DOI: 10.7326/m20-0504) (Q7925) ‎ (← links)
• Section 2.1: Selection of front-line personnel (from DOI: 10.1080/22221751.2020.1735265) (Q8396) ‎ (← links)
• Section 2.2: Isolation and protection requirements (from DOI: 10.1080/22221751.2020.1735265) (Q8397) ‎ (← links)
• Section 2.3: Isolation and observation of medical personnel after close contact with SARS-CoV-2 (from DOI: 10.1080/22221751.2020.1735265) (Q8398) ‎ (← links)
• Section 3.1: Screening criteria (from DOI: 10.1080/22221751.2020.1735265) (Q8400) ‎ (← links)
• Section 3.2: Diagnostic criteria (from DOI: 10.1080/22221751.2020.1735265) (Q8401) ‎ (← links)
• Section 3.3: Examination routines of SARS-CoV-2 infected patient (from DOI: 10.1080/22221751.2020.1735265) (Q8402) ‎ (← links)
• Section 3.4: Place of treatment according to the severity of the disease (from DOI: 10.1080/22221751.2020.1735265) (Q8405) ‎ (← links)
• Section 2.1: Biological characteristics of CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8464) ‎ (← links)
• Section 2.2: Isolation and identification of CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8465) ‎ (← links)
• Section 3.1: Major transcription factors in CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8467) ‎ (← links)
• Section 3.2: Major signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8468) ‎ (← links)
• Section 3.3: The microenvironment of CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8478) ‎ (← links)
• Section 4.1: Agents targeting CSC-associated surface biomarkers in clinical trials (from DOI: 10.1038/s41392-020-0110-5) (Q8487) ‎ (← links)
• Section 4.2: Agents targeting CSC-associated signaling pathways in clinical trials (from DOI: 10.1038/s41392-020-0110-5) (Q8488) ‎ (← links)
• Section 4.3: Targeting the CSC microenvironment (from DOI: 10.1038/s41392-020-0110-5) (Q8489) ‎ (← links)
• Section 4.4: CSC-directed immunotherapy (from DOI: 10.1038/s41392-020-0110-5) (Q8490) ‎ (← links)
• Section 3.1. Metagenomic Approach (from DOI: 10.3390/v12020211) (Q10065) ‎ (← links)
• Section 3.2. Problems of Metagenomic Approach (from DOI: 10.3390/v12020211) (Q10066) ‎ (← links)
• Section 3.3. Methods for Improving Sequencing Output (from DOI: 10.3390/v12020211) (Q10067) ‎ (← links)
• Section 3.4. Whole Viral Genome Sequencing (from DOI: 10.3390/v12020211) (Q10071) ‎ (← links)
• Section 3.5. Methods of Sequencing Data Analysis (from DOI: 10.3390/v12020211) (Q10072) ‎ (← links)
• Section 2.1: Lessons from animal models (from DOI: 10.1016/j.jcv.2020.104372) (Q10719) ‎ (← links)
• Section 2.2: Congenital and perinatal infections with coronaviruses other than SARS-CoV-2 (from DOI: 10.1016/j.jcv.2020.104372) (Q10720) ‎ (← links)
• Section 2.3: Congenital and perinatal infections with SARS-CoV-2 (from DOI: 10.1016/j.jcv.2020.104372) (Q10721) ‎ (← links)
• Section 3.1: Cardiac Complications of COVID-19 (from DOI: 10.1007/s11886-020-01293-2) (Q10989) ‎ (← links)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)